Local News: Adana, Turkey 

 | 

Sign Up

 | 

Sign In

Impax Laboratories News Editors

News Widget

Display the Impax Laboratories news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Impax Laboratories News

News on Impax Laboratories (Ticker: IPXL) continually updated from thousands of sources around the net.

Friday Feb 10 | PR-inside.com

IMPAX Laboratories, Inc. a " Product Pipeline Review a " H2 ...

A A A' Product Pipeline Review A A A' H2 2011 - a new company profile report on companiesandmarkets.com IMPAX Laboratories, Inc.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Friday Feb 10 | AmericanBankingNews.com

Impax Laboratories Shares Upgraded to "Neutral" by Zacks Investment Research Analysts.

Impax Laboratories was upgraded by Zacks Investment Research from an "underperform" rating to a "neutral" rating in a research report issued to clients and investors on Friday.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Thu Feb 09, 2012

Wall St. Cheat Sheet

Healthcare Business Review: Ironwood Pharmaceuticals Offering, Cali Medicaid Issue

Impax Laboratories provides an update on a warning letter it received about its Hayward facility.

Comment?

Related Topix: Biotech, Ironwood Pharmaceuticals, Startups, Medicine, Pharmaceuticals, Impax Laboratories, Healthcare Industry, Food and Drug Administration, Banking, Barclays plc

Drugs.com

Impax Laboratories Provides Update on Status of Warning Letter Resolution for its Hayward Facility

HAYWARD, Calif.-- --Feb 9, 2012 - Impax Laboratories, Inc. today provided an update on the status of its resolution of the previously disclosed warning letter issued by the U.S. Food and Drug Administration covering its Hayward manufacturing facility.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories, Hayward, CA, Food and Drug Administration, Marketing

Reuters

UPDATE 1-Mylan beats Impax in generic antibiotic race

Mylan Inc said it got U.S. regulatory approval to market a generic version of Warner-Chilcott's antibiotic Doryx, finishing ahead of Impax Laboratories Inc in a race to launch the copycat version.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Doxycycline (generic), Vibramycin, Doryx, Medication

Thu Feb 02, 2012

Contra Costa Times

Biz buzz

Hayward-based Impax Laboratories has bought the U.S. rights to AstraZeneca migraine headache drug Zomig, a deal that caused Impax's stock to rocket 7.5 percent higher Thursday.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories, Migraine Headache, Health, Headache, Ross Systems, Pleasanton, CA, Software

AmericanBankingNews.com

Canaccord Genuity Analysts Reiterate a "Buy" Rating on Impax Laboratories

Impax Laboratories 's stock had its "buy" rating reaffirmed by Canaccord Genuity in a research note issued on Thursday.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Wed Feb 01, 2012

Wall St. Cheat Sheet

Healthcare Business Roundup: Aetna Earnings, Novartis FDA Approval

Dendreon Corporation A names board member John Johnson as its president and Chief Executive Officer, beginning June 30.

Comment?

Related Topix: Biotech, AstraZeneca Group, Aetna, Insurance, Novartis, Dendreon, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Seeking Alpha

Wednesday Options Brief: COCO, IPXL & BEN

COCO Corinthian Colleges, Inc. Shares in the for-profit provider of post-secondary, career-oriented education programs increased as much as 44.2% to an intraday high of $4.37 at the start of the session after the Company's full-year 2012 earnings forecast of $0.30 a share beat average analyst expectations of $0.24 a share.

Comment?

Related Topix: Corinthian Colleges, Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories, Hayward, CA, Financial Services, Franklin Resources, Investment Services

MarketNewsVideo

Wednesday's ETF with Unusual Volume: XPH

The SPDR S&P Pharmaceuticals ETF is seeing unusually high volume in afternoon trading Wednesday, with over 213,000 shares traded versus three month average volume of about 65,000. Shares of XPH were up about 1.8% on the day.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Johnson and Johnson, Pharmaceuticals, Business News, Video

BioSpace

Impax Pharmaceuticals Gains Rights for US Sales of AstraZeneca PLC's...

HAYWARD, Calif.-- -- Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc.

1 comment

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, AstraZeneca, AstraZeneca Group, Hayward, CA, Startups, Impax Laboratories, Zomig, Zolmitriptan (generic), Medication

Reuters

UPDATE 1-Impax Labs licenses Astrazeneca's migraine drug in US

Impax Laboratories said it has licensed AstraZeneca's migraine treatment, Zomig, in the United States and will pay quarterly payments totaling $130 million during 2012 to the British drugmaker.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Migraine, Health, Startups, Impax Laboratories

Mon Jan 30, 2012

Stock Market Review

Perrigo Files for Generic Astepro - Analyst Blog

Perrigo Company recently announced that it has filed an application to manufacture a generic version of Meda Pharmaceuticals' Astepro nasal spray to treat nasal symptoms caused by seasonal allergies or environmental irritants.

Comment?

Related Topix: Biotech, Perrigo, Medicine, Healthcare Industry, Pharmaceuticals, Startups, Impax Laboratories

Thu Jan 26, 2012

Freshnews

Impax Laboratories Schedules Conference Call and Webcast for Fourth...

Impax Laboratories, Inc. announced today that its fourth quarter and full year 2011 financial results will be released before the market opens on Tuesday, February 28, 2012 and will be available on Impax's Web site at www.impaxlabs.com . The Company will host a conference call and live webcast with financial analysts at 11:00 a.m., Eastern Time.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Mon Jan 23, 2012

BioSpace

Perrigo Company Confirms Filing for Generic Version of Astepro(R)...

Perrigo Company Confirms Filing for Generic Version of Astepro Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals /PRNewswire/ -- Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for azelastine hydrochloride nasal spray and has notified Meda ... (more)

Comment?

Related Topix: Biotech, Perrigo, Medicine, Healthcare Industry, Food and Drug Administration, Pharmaceuticals, Startups, Impax Laboratories, Corporate / Securities Law, Law

Sat Jan 21, 2012

AmericanBankingNews.com

Impax Laboratories (IPXL) Shares Downgraded by Zacks Investment Research to "Underperform"

Impax Laboratories was downgraded by Zacks Investment Research from a "neutral" rating to an "underperform" rating in a report issued on Saturday.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Impax Laboratories

Mon Jan 16, 2012

Stock Market Review

Shire, Prasco Ink Deal - Analyst Blog

Shire recently entered into an agreement with Prasco Laboratories, a US based privately held generics company.

Comment?

Related Topix: Medicine, Carbamazepine (generic), Tegretol, Medication, Seizures, Health, Pain, Biotech, Teva Pharmaceutical Industries, Pharmaceuticals, Healthcare Industry, Mylan Laboratories

Also on Topix